The pediatrician and medical care of the child with cancer (Q35064124)

6 August 2017

1 reference

title

The pediatrician and medical care of the child with cancer (English)

1 reference

6 August 2017

Eve Golden

1 reference

6 August 2017

Barbara Beach

series ordinal

1 reference

6 August 2017

Caroline Hastings

series ordinal

1 reference

6 August 2017

publication date

1 December 2002

1 reference

Pediatric Clinics of North America

6 August 2017

published in

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

1319-38, vii

1 reference

Rural families' perspectives on having a child with cancer

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

From Both Sides Now: A Parent-Physician's View of Parent-Doctor Relationships During Pediatric Cancer Treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Shared Management of Children With Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Changes in the scope of care provided by primary care physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Phase I and pharmacokinetic study of CI-980 in recurrent pediatric solid tumor cases: a Pediatric Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Routine chest radiography for pediatric oncology patients with febrile neutropenia: is it really necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Computed tomography in the evaluation of febrile neutropenic pediatric oncology patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Meningitis in pediatric cancer patients: a review of forty cases from a single institution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Management of fever in patients with cancer and treatment-induced neutropenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Predicting the risk of bacteremia in childen with fever and neutropenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

"Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

The child with cancer and infection. II. Nonbacterial infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Acyclovir therapy of chickenpox in immunosuppressed children--a collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Progressive varicella presenting with pain and minimal skin involvement in children with acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Prevention and treatment of pneumocystis pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Prevention of bacterial endocarditis. Recommendations by the American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Effect of immunosuppressive therapy on the clinical presentation and outcome of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

The increased risk of developing tuberculosis in children with malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Herpes simplex virus infection in the immunocompromised cancer patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Acyclovir prophylaxis of herpes-simplex-virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Totally implantable central venous access devices for paediatric oncology patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

The use of venous access devices in pediatric oncology nursing practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

A prospective analysis of vascular access device-related infections in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

The use of alteplase to restore patency of central venous lines in pediatric patients: a cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Mechanical complications related to indwelling central venous catheter in pediatric hematology/oncology patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Peripheral vs. central blood cultures in patients admitted to a pediatric oncology ward

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Consequences of intravascular catheter sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Attributable Morbidity and Mortality of Catheter-Related Septicemia in Critically Ill Patients: a Matched, Risk-Adjusted, Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Optimal care of the pediatric end-stage renal disease patient on dialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: a randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Treatment with recombinant human erythropoietin in children with malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Recombinant human erythropoietin for the treatment of anemia in children with solid malignant tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Consensus Conference on Platelet Transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997. Synopsis of background papers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Meta-analysis of randomized controlled trials of the efficacy of white cell reduction in preventing HLA-alloimmunization and refractoriness to random-donor platelet transfusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Failure of granulocyte-macrophage colony-stimulating factor to reduce febrile neutropenia in children with recurrent solid tumors treated with ifosfamide, carboplatin, and etoposide chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Granulocyte-macrophage-colony stimulating factor for prevention of neutropenia and infections in children and adolescents with solid tumors. Results of a prospective randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Oncology practice patterns in the use of hematopoietic growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Recommendations on the use of colony-stimulating factors in children: conclusions of a European panel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Growth factor practice patterns among pediatric oncologists: results of a 1998 Pediatric Oncology Group Survey. Economic Evaluation Working Group the Pediatric Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Methylprednisolone for chemotherapy-induced emesis: a double-blind randomized trial in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: a meta-analysis of randomized evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Side effects of metoclopramide as an antiemetic in childhood cancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Lorazepam for the control of chemotherapy-related nausea and vomiting in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

An efficient new cannabinoid antiemetic in pediatric oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Use of unconventional therapies by children with cancer at an urban medical center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Alternative and complementary therapy use in pediatric oncology patients in British Columbia: prevalence and reasons for use and nonuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Use of Alternative Therapies for Children With Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Use of alternative therapy among pediatric oncology patients in Taiwan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Hepatic veno-occlusive disease associated with comfrey ingestion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Acute hepatitis associated with the Chinese herbal product jin bu huan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

A framework for understanding and responding to the psychosocial needs of children with Langerhans cell histiocytosis and their families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Life change events and coping behaviors in families of children with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Family coping. Supportive and obstructive factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Family functioning predictors of adjustment in children with newly diagnosed cancer: a prospective analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Guidelines for assistance to siblings of children with cancer: report of the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Siblings of a child with cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Sibling adaptation to childhood cancer collaborative study: health outcomes of siblings of children with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Randomized placebo-controlled trial of oral antibiotics in pediatric oncology patients at low-risk with fever and neutropenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

SIOP Working Committee on Psychosocial Issues in Pediatric Oncology: guidelines for school/education

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Social, emotional, and behavioral functioning of children with cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

The primary care provider's role in caring for young people with chronic illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Alterations in self-perceptions among adolescent cancer survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Guidelines for the recognition, prevention, and remediation of burnout in health care professionals participating in the care of children with cancer: report of the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

Central venous catheter infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Perspective on the management of catheter-related infections in cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900093-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(02)00093-7

1 reference

6 August 2017

1 reference